Bitcoin mania: private currencies are nothing new
The idea is gaining ground that bitcoin and the plethora of other new currencies are here to stay. But the existence of private currencies operating parallel to official ones is nothing new, says Merryn Somerset Webb.
This week is all about cryptocurrencies. In the US, crypto platform Coinbase is listing. Bitcoin is hitting regular new highs (around $64,000 now) as is ether (up 6% on Wednesday alone). And the idea that these new currencies are here to stay is gaining ground. They might be. But before you rush out to buy too much of them (John and I both have smallish holdings – we like to hedge our opinions) bear in mind that while the tech behind digital currencies is new, the existence of private currencies operating parallel to those issued by national authorities is not.
Take the tokens that circulated in 17th century London. Post-civil war – and the removal of the Royal Prerogative to mint base-metal coins – there was a shortage of state-issued small-denomination coinage available (not good for trade!). Market forces stepped in (of course!). Shopkeepers and innkeepers commissioned “moneyers” to produce personalised coins, then used these to issue change. By 1672 some 4,000 separate coins were thought to have been struck and passed around in London. They worked: as long as all merchants trusted that the merchant named on the coin was good to eventually redeem the coin for goods, that it was not state issued was not a problem. Unless, of course, you were the king, Charles II: he reckoned that private currencies took a bite out his “royal authority” and banned the lot. You may think this quaint little story of pewter tokens representing the odd half pint of beer has no bearing on your bitcoin holding. You may be right. But if you think of a cryptocurrency as a representation of value that skips a state-sponsored middle man, that can be produced by anyone and – if it has the trust of a critical mass of people – that can be used for trade by anyone, what is the real difference? Perhaps it’s just the fact that not all modern authorities are quite as confident in their power as Charles II. Yet.
For more on how money might evolve in a world where we attribute purchasing power to computer code, see China’s new digital currency. China’s government has a bit more of the Charles about it than most of the West: it might be first to suggest that its citizens should use the state-sponsored centralised digital yuan over any decentralised cryptos.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
On to a genuine modern development. I’m slightly nervous of the alternative meat sector (I worry about the health impacts of highly-processed “plant-based” meats) but in this week's magazine Jim Mellon and Anthony Chow make a compelling case for “cellular agriculture” as the best hope for the future of food – and, crucially, for animal welfare.
As podcast guest Peter Spiller of the Capital Gearing Trust tells me this week, when money supply is growing fast and people are confident, risk asset prices mostly rise (short term at least). But we still reckon that with prices where they are, if you are buying you are better to buy at the less costly end of the market – perhaps stick with the UK (only Italy and South Korea are cheaper). Finally, as we move into the part of the pandemic when we start to get a sense of who are the lockdown wrecked and who are the lockdown winners, it’s worth remembering who’s done best this year – American CEOs. Their average pay is up by a million bucks-odd a head and they seem to have spent even more time than usual going on holiday by private jet. Nice work if you can get it.
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Merryn Somerset Webb started her career in Tokyo at public broadcaster NHK before becoming a Japanese equity broker at what was then Warburgs. She went on to work at SBC and UBS without moving from her desk in Kamiyacho (it was the age of mergers).
After five years in Japan she returned to work in the UK at Paribas. This soon became BNP Paribas. Again, no desk move was required. On leaving the City, Merryn helped The Week magazine with its City pages before becoming the launch editor of MoneyWeek in 2000 and taking on columns first in the Sunday Times and then in 2009 in the Financial Times
Twenty years on, MoneyWeek is the best-selling financial magazine in the UK. Merryn was its Editor in Chief until 2022. She is now a senior columnist at Bloomberg and host of the Merryn Talks Money podcast - but still writes for Moneyweek monthly.
Merryn is also is a non executive director of two investment trusts – BlackRock Throgmorton, and the Murray Income Investment Trust.
-
Higher rates are disappearing – should you fix your savings?
Fixed savings rates have dropped to their lowest levels in over a year. Should you fix your savings now ahead of a potential base rate cut in November?
By Katie Williams Published
-
Nine million people fall victim to financial scams, says Citizens Advice
The charity says that around one in five people across the UK have been caught out by a finance scam in the past year - here is how to protect your money
By Chris Newlands Published
-
What will a broken-up Google look like?
The US courts have ruled that Google is a monopoly, leaving it facing the prospect of a break-up. WIll that be a good thing?
By Matthew Lynn Published
-
How will the UK gambling sector be hit by the Budget?
There are concerns for the UK gambling sector in the lead-up to the Autumn Budget. What could be on the cards?
By Dr Matthew Partridge Published
-
HSBC returns to cost-cutting plan
HSBC is set to revamp its commercial banking division – but will it come at a cost?
By Dr Matthew Partridge Published
-
Pfizer shares rise as US investor takes $1 billion stake
Pfizer shares are on the up since US activist investor Starboard Value built up a stake in the drug maker. But strategic options appear limited
By Dr Matthew Partridge Published
-
Qualcomm could acquire rival Intel – but securing the deal won't be easy
A tie-up between Qualcomm and its semiconductor rival Intel would be a coup. But multiple regulatory and commercial hurdles lie ahead.
By Dr Matthew Partridge Published
-
How to invest in the quiet market months
Here's how to invest in the quiet market months, since “sell in May” hasn’t paid off this year.
By Cris Sholto Heaton Published
-
Spire Healthcare: invest in the booming demand for private healthcare
Spire Healthcare is one of the few listed companies benefiting from the growing trend in private healthcare. Should you invest?
By Rupert Hargreaves Published
-
Are insurance companies a good investment?
Costs may be soaring but the insurance sector is currently going through one of its most profitable periods. The market has been slow to realise the opportunity here
By Rupert Hargreaves Published